Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 131,105 | 0.00 | 47,688 | 0.00 | 0.00 |
| Operating Revenue | 131,105 | 0.00 | 47,688 | 0.00 | 0.00 |
| Cost Of Revenue | 103,294 | 31,874 | 30,803 | 38,482 | 38,999 |
| Gross Profit | 27,811 | -31,874 | 16,885 | -38,482 | -38,999 |
| Selling General And Administration | 608,473 | 406,019 | 379,699 | 396,823 | 340,560 |
| General And Administrative Expense | 523,260 | 375,544 | 319,430 | 367,908 | 339,226 |
| Other Operating Expenses | 63,479 | 118,132 | 154,094 | 179,875 | 98,049 |
| Operating Expense | 671,952 | 524,151 | 533,793 | 576,698 | 438,609 |
| Operating Income | -644,141 | -556,025 | -516,908 | -615,180 | -477,608 |
| EBIT | -644,141 | -556,025 | -516,908 | -615,180 | -477,608 |
| Interest Income | 111,077 | 96,043 | 80,243 | 206,426 | 202,034 |
| Interest Income Non Operating | 111,077 | 96,043 | 80,243 | 206,426 | 202,034 |
| Net Interest Income | 111,077 | 132,103 | 158,445 | 198,113 | 306,444 |
| Other Income Expense | 1.7M | -1.2M | 984,877 | 1.5M | 590,928 |
| Other Non Operating Income Expenses | 28,417 | -76,138 | 1.2M | -71,833 | 695,281 |
| Special Income Charges | -35,345 | -30,178 | -13,087 | 345,576 | 331,512 |
| Gain On Sale Of Security | 1.8M | -1.1M | -163,057 | 1.3M | -435,865 |
| Earnings From Equity Interest | -16,897 | -37,962 | -8,369 | -- | 0.00 |
| Pretax Income | 1.2M | -1.6M | 626,414 | 1.1M | 419,764 |
| Tax Provision | -181,373 | -- | -- | 20,009 | -201,383 |
| Tax Effect Of Unusual Items | 259,403 | 0.00 | -26,422 | 28,928 | -15,653 |
| Net Income From Continuing And Discontinued Operation | 1.4M | -1.6M | 626,414 | 1.1M | 621,147 |
| Net Income From Continuing Operation Net Minority Interest | 1.4M | -1.6M | 626,414 | 1.1M | 621,147 |
| Net Income Including Noncontrolling Interests | 1.4M | -1.6M | 626,414 | 1.1M | 621,147 |
| Net Income Common Stockholders | 1.4M | -1.6M | 626,414 | 1.1M | 621,147 |
| Net Income | 1.4M | -1.6M | 626,414 | 1.1M | 621,147 |
| EBITDA | -614,876 | -524,151 | -486,105 | -576,698 | -438,609 |
| Normalized EBITDA | -2.3M | 583,860 | -309,961 | -2.2M | -334,256 |
| Reconciled Depreciation | 29,265 | 31,874 | 30,803 | 38,482 | 38,999 |
| Basic EPS | 0.02 | -0.03 | 0.01 | -- | 0.01 |
| Diluted EPS | 0.02 | -0.03 | 0.01 | -- | 0.01 |
| Basic Average Shares | 61.0M | 61.0M | 61.0M | -- | 61.0M |
| Diluted Average Shares | 61.6M | 61.0M | 61.0M | -- | 61.0M |
| Total Unusual Items | 1.7M | -1.1M | -176,144 | 1.6M | -104,353 |
| Total Unusual Items Excluding Goodwill | 1.7M | -1.1M | -176,144 | 1.6M | -104,353 |
| Tax Rate For Calcs | 0.15 | 0.00 | 0.15 | 0.02 | 0.15 |
| Normalized Income | -80,768 | -538,022 | 776,136 | -489,425 | 709,847 |
| Diluted NI Availto Com Stockholders | 1.4M | -1.6M | 626,414 | 1.1M | 621,147 |
| Gain On Sale Of Ppe | -10,252 | 0.00 | -511.00 | -6,814 | 407,924 |
| Impairment Of Capital Assets | 25,093 | 30,178 | 12,576 | 20,551 | 76,412 |
| Net Income Continuous Operations | 1.4M | -1.6M | 626,414 | 1.1M | 621,147 |
| Net Non Operating Interest Income Expense | 111,077 | 132,103 | 158,445 | 198,113 | 306,444 |
| Other Gand A | 347,057 | 342,744 | 319,430 | 367,908 | 337,476 |
| Reconciled Cost Of Revenue | 103,294 | 31,874 | 30,803 | 38,482 | 38,999 |
| Salaries And Wages | 176,203 | 32,800 | -- | 0.00 | 1,750 |
| Selling And Marketing Expense | 85,213 | 30,475 | 60,269 | 28,915 | 1,334 |
| Total Expenses | 775,246 | 556,025 | 564,596 | 615,180 | 477,608 |
| Total Other Finance Cost | -- | -36,060 | -78,202 | 8,313 | -104,410 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 8.6M | 10.3M | 12.2M | 12.9M | 13.2M |
| Cash Cash Equivalents And Short Term Investments | 19.9M | 11.1M | 13.1M | 13.9M | 14.4M |
| Cash Equivalents | -- | -- | 10.5M | -- | 11.5M |
| Cash Financial | -- | -- | 1.7M | -- | 1.8M |
| Other Short Term Investments | 11.3M | 857,835 | 872,356 | 1.0M | 1.1M |
| Accounts Receivable | 166,637 | 49,309 | 29,224 | 160,818 | 111,968 |
| Receivables | 166,637 | 49,309 | 29,224 | 160,818 | 111,968 |
| Prepaid Assets | 155,777 | 111,265 | 40,315 | 72,636 | 72,728 |
| Current Assets | 20.3M | 11.3M | 13.2M | 14.2M | 14.5M |
| Gross PPE | 8.9M | 7.6M | 6.8M | 6.5M | 6.0M |
| Accumulated Depreciation | -1.1M | -1.2M | -1.1M | -1.1M | -1.2M |
| Net PPE | 7.8M | 6.4M | 5.7M | 5.4M | 4.8M |
| Investments And Advances | 156,489 | 173,386 | 211,348 | 219,717 | -- |
| Long Term Equity Investment | 156,489 | 173,386 | 211,348 | 219,717 | -- |
| Other Non Current Assets | 150,736 | 146,978 | 148,467 | 139,223 | 131,978 |
| Total Non Current Assets | 8.2M | 15.8M | 15.6M | 14.0M | 12.5M |
| Total Assets | 28.5M | 27.1M | 28.8M | 28.2M | 27.0M |
| Accounts Payable | 321,791 | 253,653 | 356,567 | 395,422 | 241,316 |
| Payables | 321,791 | 253,653 | 356,567 | 395,422 | 339,995 |
| Payables And Accrued Expenses | 321,791 | 253,653 | 356,567 | 395,422 | 339,995 |
| Current Liabilities | 321,791 | 253,653 | 356,567 | 395,422 | 339,995 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 321,791 | 253,653 | 356,567 | 395,422 | 339,995 |
| Common Stock | 23.6M | 23.6M | 23.6M | 23.6M | 23.6M |
| Capital Stock | 23.6M | 23.6M | 23.6M | 23.6M | 23.6M |
| Retained Earnings | 2.1M | 750,846 | 2.4M | 1.8M | 672,467 |
| Common Stock Equity | 28.2M | 26.8M | 28.4M | 27.8M | 26.7M |
| Stockholders Equity | 28.2M | 26.8M | 28.4M | 27.8M | 26.7M |
| Total Equity Gross Minority Interest | 28.2M | 26.8M | 28.4M | 27.8M | 26.7M |
| Total Capitalization | 28.2M | 26.8M | 28.4M | 27.8M | 26.7M |
| Net Tangible Assets | 28.2M | 26.8M | 28.4M | 27.8M | 26.7M |
| Tangible Book Value | 28.2M | 26.8M | 28.4M | 27.8M | 26.7M |
| Working Capital | 19.9M | 11.0M | 12.8M | 13.8M | 14.2M |
| Invested Capital | 28.2M | 26.8M | 28.4M | 27.8M | 26.7M |
| Share Issued | 61.2M | 61.0M | 61.0M | 61.0M | 61.0M |
| Ordinary Shares Number | 61.2M | 61.0M | 61.0M | 61.0M | 61.0M |
| Dueto Related Parties Current | -- | -- | -- | -- | 98,679 |
| Investmentsin Associatesat Cost | 156,489 | 173,386 | 211,348 | 219,717 | -- |
| Machinery Furniture Equipment | 358,438 | 422,811 | 422,811 | 473,826 | 559,049 |
| Non Current Deferred Assets | 160,266 | 160,266 | 160,266 | 160,266 | 180,275 |
| Non Current Deferred Taxes Assets | 160,266 | 160,266 | 160,266 | 160,266 | 180,275 |
| Non Current Note Receivables | 0.00 | 8.9M | 9.4M | 8.1M | 7.3M |
| Other Equity Interest | 2.5M | 2.5M | 2.5M | 2.5M | 2.5M |
| Other Properties | 137,473 | 137,473 | 137,473 | 137,473 | 100,877 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -194,104 | -1.1M | -342,901 | 468,645 | -296,326 |
| Cash Flow From Continuing Operating Activities | -194,104 | -1.1M | -342,901 | 468,645 | -296,326 |
| Depreciation And Amortization | 29,265 | 31,874 | 30,803 | 38,482 | 38,999 |
| Depreciation Amortization Depletion | 29,265 | 31,874 | 30,803 | 38,482 | 38,999 |
| Stock Based Compensation | 7,500 | 32,800 | -- | 0.00 | 1,750 |
| Change In Working Capital | -67,565 | -148,813 | 66,514 | 266,722 | -86,267 |
| Changes In Account Receivables | -161,840 | -91,035 | 163,915 | 126,178 | -18,398 |
| Change In Receivables | -161,840 | -91,035 | 163,915 | 126,178 | -18,398 |
| Change In Payables And Accrued Expense | 94,275 | -57,778 | -97,401 | 140,544 | -67,869 |
| Change In Payable | 94,275 | -57,778 | -97,401 | 140,544 | -67,869 |
| Other Non Cash Items | -28,417 | 40,078 | -1.2M | -292,795 | -799,691 |
| Capital Expenditure | -- | -- | -25,712 | -57,807 | -1.3M |
| Purchase Of PPE | 0.00 | 0.00 | -25,712 | -57,807 | 0.00 |
| Net PPE Purchase And Sale | 14,464 | 0.00 | -4,818 | -5,185 | 677.00 |
| Investing Cash Flow | -1.4M | -837,493 | -308,015 | -822,067 | -1.3M |
| Cash Flow From Continuing Investing Activities | -1.4M | -837,493 | -308,015 | -822,067 | -1.3M |
| Financing Cash Flow | -40,791 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow From Continuing Financing Activities | -40,791 | -- | -- | 0.00 | 0.00 |
| Changes In Cash | -1.7M | -2.0M | -650,916 | -353,422 | -1.6M |
| Beginning Cash Position | 10.3M | 12.2M | 12.9M | 13.2M | 14.9M |
| End Cash Position | 8.6M | 10.3M | 12.2M | 12.9M | 13.2M |
| Free Cash Flow | -194,104 | -1.1M | -368,613 | 410,838 | -296,326 |
| Asset Impairment Charge | 25,093 | 30,178 | 12,576 | 20,551 | 76,412 |
| Depreciation | 29,265 | 31,874 | 30,803 | 38,482 | 38,999 |
| Earnings Losses From Equity Investments | 16,897 | 37,962 | 8,369 | -- | 0.00 |
| Gain Loss On Sale Of PPE | 10,252 | 0.00 | 511.00 | 6,814 | -407,924 |
| Net Foreign Currency Exchange Gain Loss | -71,447 | 484,281 | -10,031 | -490,683 | 91,058 |
| Net Income From Continuing Operations | 1.4M | -1.6M | 626,414 | 1.1M | 621,147 |
| Net Other Financing Charges | -40,791 | -- | -- | -- | -- |
| Net Other Investing Changes | -1.4M | -837,493 | -303,197 | -661,721 | -1.3M |
| Operating Gains Losses | -44,298 | 522,243 | -1,151 | -474,425 | -316,866 |
| Sale Of PPE | 14,464 | 0.00 | 20,894 | 52,622 | 677.00 |
| Unrealized Gain Loss On Investment Securities | -1.5M | 14,521 | 169,535 | -6,514 | 168,190 |